Radicava ORS – Patient Worthy

qimono / Pixabay

Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

Post author:Rose Duesterwald
Post published:May 25, 2022
Post category:Amyotrophic Lateral Sclerosis

The new FDA-approved oral formulation of Radicava ORS (edaravone) is more convenient than the intravenous formulation, yet the efficacy and composition remain the same. The oral formulation may also be…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More